Clinical oncology next generation sequencing Market Forecast Hit by Coronavirus Outbreak, Downside Risks Continue to Esc
Clinical oncology next generation sequencing Market: Global Industry Analysis 2014-2018 & Opportunity Assessment 2019-2029 A recent market study published by FMI u201cClinical oncology next generation sequencing Market: Global Industry Analysis 2014-2018 & Forecast 2019-2029u201d offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historic as well as current growth parameters of the clinical oncology next generation sequencing market, the growth prospects of the market are obtained with maximum precision. CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET TAXONOMY The global clinical oncology next generation sequencing market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach in front of the reader. By Product Sequencing Platforms Sequencing Products Kits and Reagents Services Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-9543 By Technology Ion Semiconductor Sequencing Pyro-Sequencing Synthesis Sequencing (SBS) Real Time Sequencing (SMRT) Ligation Sequencing Reversible Dye Termination Sequencing Nano-Pore Sequencing By Application Whole Tumor Genome Sequencing Whole Tumor Exome Sequencing Targeted Tumor Genome Profiling Tumor Transcriptome Sequencing Tumor-normal Comparisons Others By End User Hospital Laboratories Clinical Research Organizations Diagnostic Laboratories Others Region North America Latin America Europe East Asia South Asia Oceania Middle East & Africa WHAT'S INCLUDED Chapter 01 u2013 Executive Summary The report commences with the executive summary of the clinical oncology next generation sequencing market, which includes a summary of the key findings and key statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the clinical oncology next generation sequencing market. Chapter 02 u2013 Market Overview Readers can find the detailed taxonomy and the definition of the Clinical oncology next generation sequencing market in this chapter, which will help them understand the basic information about the clinical oncology next generation sequencing market. This section also highlights the inclusions and exclusions, which helps the reader understand the scope of the clinical oncology next generation sequencing market report. Chapter 03 u2013 Key Market Trends The report provides key market trends that are expected to impact the market growth significantly during the forecast period. Detailed industry trends are provided in this section, along with key market development or product innovations. Chapter 04 u2013 Key Success Factors This section includes the key inclusions of the report. It includes product adoption & usage analysis, reimbursement scenario, pipeline assessment & opportunity analysis, and manufactures strategies for market expansion. Chapter 05 u2013 Global Clinical oncology next generation sequencing Market Demand (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029 This section explain the global market value analysis and forecast for the clinical oncology next generation sequencing market between the forecast periods of 2014-2029 is highlights in this section. This chapter includes the detailed analysis of the historical clinical oncology next generation sequencing market, along with an opportunity analysis of the future. Readers can also find the absolute opportunity for the current year (2019 u2013 2020), and an incremental opportunity for the forecast period (2019 u2013 2029). Chapter 06 u2013 Global Clinical oncology next generation sequencing Market Pricing Analysis This section highlights the average price of clinical oncology next generation sequencing. The pricing benchmark for manufacturer level pricing and distributor level pricing is analysed in this section. Chapter 07 u2013 Global Clinical oncology next generation sequencing Market Demand (Volume in Units) Analysis 2014-2018 and Forecast, 2019-2029 This section explain the global market volume analysis and forecast for the Clinical oncology next generation sequencing market between the forecast periods of 2019-2029 is highlights in this section. Chapter 08 u2013 Market Background This chapter explains the key macro-economic factors that are expected to influence the growth of the Clinical oncology next generation sequencing market over the forecast period. Along with macroeconomic factors, this section also highlights the opportunity analysis for the Clinical oncology next generation sequencing market. This chapter also highlights the key market dynamics of the clinical oncology next generation sequencing market, which include the drivers, restraints and trends. Moreover, readers will understand the key trends followed by the leading manufacturers in the clinical oncology next generation sequencing market. Chapter 09 u2013 Global Clinical oncology next generation sequencing Market Analysis 2014 - 2018 & Forecast 2019 - 2029, By Product Type Based on product type, the clinical oncology next generation sequencing market is segmented into sequencing Platforms, sequencing products, kits and reagents services. In this chapter, readers can find information about the key trends and developments in the clinical oncology next generation sequencing market and market attractiveness analysis based on the product type. Chapter 10 u2013 Global Clinical oncology next generation sequencing Market Analysis 2014 - 2018 & Forecast, 2019 - 2029, By technology This chapter provides details about the clinical oncology next generation sequencing market on the basis of technology, and has been classified into ion semiconductor sequencing, pyro-sequencing, synthesis sequencing (SBS), real time sequencing (SMRT), ligation sequencing, reversible dye termination sequencing and nano-pore sequencing. In this chapter, readers can understand the market attractive analysis based on disease indication. Chapter 11 u2013 Global Clinical oncology next generation sequencing Market Analysis 2014 - 2018 & Forecast, 2019 - 2029, By Application This chapter provides details about the clinical oncology next generation sequencing market on the basis of application, and has been classified into whole tumor genome sequencing, whole tumor exome sequencing, targeted tumor genome profiling, tumor transcriptome sequencing, tumor-normal comparisons and others In this chapter, readers can understand the market attractive analysis based on application. Chapter 12 u2013 Global Clinical oncology next generation sequencing Market Analysis 2014 - 2018 & Forecast, 2019 - 2029, By End User This chapter provides details about the clinical oncology next generation sequencing market on the basis of end user, and has been classified into hospital laboratories, clinical research organizations, diagnostic laboratories and others. In this chapter, readers can understand the market attractive analysis based on end user. Chapter 13 u2013 Global Clinical oncology next generation sequencing Market Analysis 2014 u2013 2018 & Forecast, 2019 - 2029, By Region This chapter explains how the clinical oncology next generation sequencing market will grow across various geographic regions, such as North America, Latin America, Europe, East Asia, South Asia, Oceania, the Middle East & Africa (MEA) Chapter 14 u2013 North America Clinical oncology next generation sequencing Market Analysis 2014 u2013 2018 & Forecast, 2019 - 2029 This chapter includes a detailed analysis of the growth of the North America clinical oncology next generation sequencing market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find the regional trends, regulations, and market growth based on the end users and countries in North America. Chapter 15 u2013 Latin America Clinical oncology next generation sequencing Market Analysis 2014 - 2018 & Forecast, 2019 - 2029 Readers can find detailed information about several factors, such as the pricing analysis and the regional trends, which are impacting the growth of the Latin America clinical oncology next generation sequencing market. This chapter also includes the growth prospects of the clinical oncology next generation sequencing market in the leading LATAM countries such as Brazil, Mexico, Argentina, and the Rest of Latin America. Chapter 16 u2013 Europe Clinical oncology next generation sequencing Market Analysis 2014 - 2018 & Forecast, 2019 - 2029 Important growth prospects of the clinical oncology next generation sequencing market based on its end users in several countries, such as Germany, the UK, France, Spain, Italy, Russia, and the Rest of Europe, are included in this chapter. Chapter 17 u2013 South Asia Clinical oncology next generation sequencing Market Analysis 2014 - 2018 & Forecast, 2019 - 2029 India, Indonesia, Thailand , Malaysia are the leading countries in the South Asia region that are the prime subjects of assessment to obtain the growth prospects of the South Asia clinical oncology next generation sequencing market in this chapter. Readers can find detailed information about the growth parameters of the South Asia clinical oncology next generation sequencing market during the period 2019-2029. Chapter 18 u2013 East Asia Clinical oncology next generation sequencing Market Analysis 2014 - 2018 & Forecast, 2019 - 2029 This chapter highlights the growth of the clinical oncology next generation sequencing market in the East Asia by focusing on China, Japan and South Korea. This section also helps readers understand the key factors that are responsible for the growth of the clinical oncology next generation sequencing market in East Asia. Chapter 19 u2013 Oceania Clinical oncology next generation sequencing Market Analysis 2014 - 2018 & Forecast, 2019 - 2029 In this chapter, Australia and New Zealand are among the leading countries in the Oceania region, which are the prime subjects of assessment to obtain the growth prospects of the Oceania clinical oncology next generation sequencing market. Chapter 20 u2013 MEA Clinical oncology next generation sequencing Market Analysis 2014 - 2018 & Forecast, 2019 - 2029 This chapter provides information about how the clinical oncology next generation sequencing market will grow in the major countries in the MEA region, such as GCC Countries, South Africa, Turkey, Northern Africa and the rest of MEA, during the forecast period 2019 - 2029. Sample of Research Methodology Report @ https://www.futuremarketinsights.com/askus/rep-gb-9543 Chapter 21 u2013 Market Structure Analysis In this chapter, readers can find a detailed information about the tier analysis and market concentration of the key players in the clinical oncology next generation sequencing market along with their market presence analysis by region and product portfolio. Chapter 22 u2013 Competition Analysis In this chapter, readers can find a comprehensive list of all the leading stakeholders in the Clinical oncology next generation sequencing market, along with detailed information about each company, which includes the company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are Illumina Inc., Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd., Pacific Biosciences of California, Inc., Oxford Nanopore Technologies, Ltd., Agilent Technologies, Inc., QIAGEN N.V., Takara Bio, Inc., and PerkinElmer Inc. Chapter 23 u2013 Assumptions and Acronyms This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the clinical oncology next generation sequencing report. Chapter 24u2013 Research Methodology This chapter helps readers understand the research methodology followed to obtain the various conclusions as well as important qualitative and quantitative information about the clinical oncology next generation sequencing market. ABOUT US: Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India. FMIu2019s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers. CONTACT US: Future Market Insights U.S. Office 616 Corporate Way, Suite 2-9018, Valley Cottage, NY 10989, United States T: 1-347-918-3531 F: 1-845-579-5705 Web: https://www.futuremarketinsights.com
168 views • 15 slides
